INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL (THE)

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 21234
 
  
 
C07D HETEROCYCLIC COMPOUNDS 18144
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 3164
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 3203
 
  
 
G06T IMAGE DATA PROCESSING OR GENERATION, IN GENERAL 2133
 
  
 
A61B DIAGNOSIS; SURGERY; IDENTIFICATION 1239
 
  
 
C07C ACYCLIC OR CARBOCYCLIC COMPOUNDS 1137
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 198
 
  
 
C07K PEPTIDES 1135
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 1124

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2017/0319,543 DNA DAMAGE REPAIR INHIBITORS FOR TREATMENT OF CANCERMay 12, 17Nov 09, 17[A61K]
2016/0130,564 VACCINIA VIRUS FOR GENE-DIRECTED ENZYME PRODRUG THERAPYJun 18, 14May 12, 16[A61K, C12N]
2015/0182,122 ULTRASONIC IMAGINGJul 24, 13Jul 02, 15[G06T, A61B]
2014/0378,525 MATERIALS AND METHODS FOR TREATING PTEN MUTATED OR DEFICIENT CANCERJun 08, 12Dec 25, 14[A61K, C12N, G01N]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9820976 1-(5-tert-butyl-2-phenyl-2H-pyrazol-3-yl)-3-[2-fluoro-4-(1-methyl-2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-7-yloxy)-phenyl]-urea and related compounds and their use in therapySep 01, 16Nov 21, 17[A61K, C07D]
9725447 1-(5-tert-butyl-2-aryl-pyrazol-3-yl)-3-[2-fluoro-4-[(3-oxo-4H-pyrido[2,3-b]pyrazin-8-yl)oxy]phenyl]urea derivatives as RAF inhibitors for the treatment of cancerNov 25, 14Aug 08, 17[C07D]
9708317 Process for the preparation of 8-(4-aminophenoxy)-4H-pyrido[2,3-B]pyrazin-3-one derivativesNov 25, 14Jul 18, 17[C07D]
9611223 3-aryl-5-substituted-isoquinolin-1-one compounds and their therapeutic useSep 11, 14Apr 04, 17[C07F, C07D, C07C]
9550764 Fused heterocyclic compounds and their useAug 22, 13Jan 24, 17[C07D]
9540372 Pyrido[2,3-b]pyrazin-8-substituted compounds and their useSep 14, 15Jan 10, 17[A61K, C07D]
9512486 Materials, methods, and systems for treating cancerAug 06, 13Dec 06, 16[A61K, C12Q]
9439893 1-(5-tert-butyl-2-phenyl-2H-pyrazol-3-yl)-3-[2-fluoro-4-(1-methyl-2-oxo-2,3-dihydro-1H-imidazo[4,5-B]pyridin-7-yloxy)-phenyl]-urea and related compounds and their use in therapyJul 30, 15Sep 13, 16[A61K, C07D]
9283226 Pyrazole derivatives as protein kinase modulatorsFeb 14, 14Mar 15, 16[A61K, C07D]
9193689 3-aryl-5-substituted-isoquinolin-1-one compounds and their therapeutic useMar 07, 13Nov 24, 15[A61K, C07D]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2015/0329,911 NUCLEIC ACID BIOMARKERS FOR PROSTATE CANCERAbandonedOct 10, 13Nov 19, 15[C12Q]
8541461 Pharmaceutical combinations comprising pyrazole derivatives as protein kinase modulatorsExpiredJun 21, 06Sep 24, 13[A61K]
8383816 Aryl-quinolyl compounds and their useExpiredApr 27, 09Feb 26, 13[C07D]
2012/0135,983 DNA Damage Repair Inhibitors for the Treatment of CancerAbandonedNov 01, 11May 31, 12[A61K, C12Q, G01N, A61P]
7855182 Materials and methods for treatment of cancerExpiredMar 22, 05Dec 21, 10[A61K]
2010/0210,617 Aryl-Alkylamines And Heteroaryl-Alkylamines As Protein Kinase InhibitorsAbandonedJun 21, 06Aug 19, 10[A61K, C07D, A61P]
2010/0130,496 PYRIMIDINE DERIVATIVES AS INHIBITORS OF PHOSPHATIDYLINOSITOL-3-KINASEAbandonedApr 14, 08May 27, 10[A61K, C07D, A61P]
2010/0120,798 SUBSTITUTED PIPERIDINES CONTAINING A HETEROARYLAMIDE OR HETEROARYLPHENYL MOIETYAbandonedDec 20, 07May 13, 10[A61K, C07D, A61P]
2010/0113,551 COMPOSITIONS COMPRISING (S)-2-AMINO-1-(4-CHLOROPHENYL)-1-[4-(1H-PYRAZOL-4-YL)-PHENYL]-ETHANOL AS MODULATOR OF PROTEIN KINASESAbandonedMar 14, 08May 06, 10[A61K, C07D, C07C]
2010/0093,748 SUBSTITUTED PIPERIDINES HAVING PROTEIN KINASE INHIBITING ACTIVITYAbandonedDec 21, 07Apr 15, 10[A61K, C07D]
7696204 Pharmaceutical compoundsExpiredOct 11, 06Apr 13, 10[A61K, C07D]
2010/0016,340 PHARMACEUTICAL COMPOUNDSAbandonedApr 25, 07Jan 21, 10[A61K, C07D, A61P]
2009/0253,718 Pharmaceutical CompoundsAbandonedApr 25, 07Oct 08, 09[A61K, A61P]
2009/0221,910 LOCATION AND STABILIZATION DEVICEAbandonedOct 09, 06Sep 03, 09[A61B]
2009/0156,601 PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF CANCERAbandonedOct 10, 06Jun 18, 09[A61K, C07D, A61P]
2009/0124,610 PHARMACEUTICAL COMPOUNDSAbandonedApr 25, 07May 14, 09[A61K, C07D]
2009/0099,213 Ortho-Condensed Pyridine and Pyrimidine Derivatives (e.g., Purines) as Protein Kinases InhibitorsAbandonedOct 25, 05Apr 16, 09[A61K, C07D, A61P]
2009/0082,370 Pharmaceutical Combinations of PK Inhibitors and Other Active AgentsAbandonedApr 25, 07Mar 26, 09[A61K, C07D, A61P]
2009/0069,336 PYRIMIDOTHIOPHENE COMPOUNDSAbandonedJul 18, 05Mar 12, 09[A61K, C07D, A61P]
2008/0275,029 Compounds for Treating Protein-Kinase Mediated DisordersAbandonedNov 09, 05Nov 06, 08[A61K, C07D, C12N, A61P]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.